Assessment of 2,2-dimethoxy-2-phenylacetophenone toxicity and hazard
https://doi.org/10.47470/0016-9900-2025-104-12-1741-1748
EDN: luesxg
Abstract
Introduction. 2,2-Dimethoxy-2-phenylacetophenone is a widely used photoinitiator applied in various industries, including the production of varnishes, paints, dental materials, and coatings. However, despite its widespread use, the toxicological properties of this compound remain to be insufficiently studied.
The aim of this study. To investigate the toxicity and potential hazards of 2,2-dimethoxy-2-phenylacetophenone.
Materials and methods. Toxicological studies were conducted to assess the effects of the substance on warm-blooded animals. The experiments included evaluation of acute toxicity via oral, dermal, and inhalation exposure routes; evaluation of cumulative properties; assessment of irritation effects on the mucous membranes of the eyes and intact skin; as well as dermal resorptive and sensitizing effects.
Results. The study showed 2,2-dimethoxy-2-phenylacetophenone to belong to hazard class 4 (low hazard substances) when administered orally (DL50 > 5000 mg/kg). In acute dermal exposure tests, no animal mortality was observed (DL50 for rats > 2500 mg/kg). The substance does not exhibit skin irritant properties but can cause irritation to the mucous membranes of the eyes. No dermal resorptive effect was detected. The substance is not an allergen and does not exhibit cumulative properties. 2,2-Dimethoxy-2-phenylacetophenone is characterized by low volatility. During the study of acute inhalation toxicity, the maximum attainable concentration was 500 mg/m³. Therefore, the substance can be classified as moderately hazardous by the inhalation route of exposure.
Limitations. Due to the low volatility of 2,2-dimethoxy-2-phenylacetophenone and the technical limitations of the inhalation system, the study of acute inhalation toxicity was conducted at only one concentration.
Conclusion. The results of the toxicological studies indicate 2,2-dimethoxy-2-phenylacetophenone to belong to hazard class III (moderately hazardous substances). Considering its widespread use, presence in industrial emissions, and the consequent exposure risk to populations living near such facilities, further studies are recommended to evaluate its chronic toxicity, long-term effects, and carcinogenic potential.
Compliance with ethical standards. The study was conducted in accordance with generally accepted ethical guidelines for the use of laboratory animals and was approved by the Bioethics Committee of the Centre for Strategic Planning of the Centre for Strategic Planning of the Federal medical and biological agency, (meeting protocol No. 5 dated 09/18/2024).
Contribution:
Fedotova L.A. – study concept and design, editing;
Mamonov R.A. – study concept and design, editing;
Pechnikova I.A. – study concept and design, collection and processing of material;
Lebed-Sharlevich Ya.I. – writing text and data analysis, collection and processing of material;
Manaeva E.S. – writing text and data analysis, collection and processing of material;
Potapchenko T.D. – writing text and data analysis, collection and processing of material;
Belyaeva N.I. – collection and processing of material;
Gollandtseva A.I. – collection and processing of material;
Nemtseva Yu.S. – collection and processing of material;
Tyurina I.A. – collection and processing of material;
Fedortsova D.Yu. – collection and processing of material;
Fedortsov I.A. – collection and processing of material;
Bolekhan V.N. – editing.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.
Conflict of interest. The authors declare no conflict of interest.
Funding. The study had no sponsorship.
Received: April 22, 2025 / Revised: August 6, 2025 / Accepted: December 2, 2025 / Published: January 15, 2026
About the Authors
Lionella A. FedotovaРоссия
PhD (Medicine), leading researcher, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: LFedotova@cspfmba.ru
Roman A. Mamonov
Россия
PhD (Medicine), head, Department, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: RMamonov@cspfmba.ru
Irina A. Pechnikova
Россия
PhD (Medicine), leading researcher, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: IPechnikova@cspfmba.ru
Yana I. Lebed-Sharlevich
Россия
PhD (Biology), senior researcher, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: YaSharlevich@cspfmba.ru
Elizaveta S. Manaeva
Россия
PhD (Biology), senior researcher, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: EManaeva@cspfmba.ru
Timur D. Potapchenko
Россия
PhD (Engineering), researcher, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: TPotapchenko@cspfmba.ru
Nadezda I. Belyaeva
Россия
PhD (Biology), leading biologist, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: NBelyaeva@cspfmba.ru
Aleksandra I. Gollandtseva
Россия
Chemist, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: AGollandtseva@cspfmba.ru
Yuliya S. Nemtseva
Россия
Biologist, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: IUNemtseva@cspfmba.ru
Irina A. Tyurina
Россия
Biologist, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: ITurina@cspfmba.ru
Darya Yu. Fedortsova
Россия
Biologist, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: DFedortsova@cspfmba.ru
Ilya A. Fedortsov
Россия
Laboratory assistant, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: IFedortsov@cspfmba.ru
Vasily N. Bolekhan
Россия
DSc (Medicine), associate professor, director, Federal Information and Analytical Center for Monitoring Medical and Biological Risks of the Federal medical and biological agency of Russia, Centre for Strategic Planning of the Federal medical and biological agency, Moscow, 119121, Russian Federation
e-mail: vbolekhan@cspfmba.ru
References
1. Yudin S.M., ed. On Guard for the Protection of Environmental Objects and Public Health [Na strazhe zashchity ob”ektov sredy i zdorov’ya naseleniya: monografiya]. Moscow: Kvant Media; 2024. (in Russian)
2. Mamonov R.A., Lebed-Sharlevich Ya.I., Manaeva E.S., Pechnikova I.A., Sinitsyna O.O. Hygienic regulation of harmful chemicals in water – a view through the prism of research by the A.N. Sysin research institute. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2024; 103(10): 1261–72. https://doi.org/10.47470/0016-9900-2024-103-10-1261-1272 https://elibrary.ru/vsyubw (in Russian)
3. Fedotova L.A., Potapchenko T.D. The history of the development of atmospheric air hygiene in historical milestones and persons of the A.N. Sysin institute. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2024; 103(10): 1257–60. https://doi.org/10.47470/0016-9900-2024-103-10-1257-1260 https://elibrary.ru/npbvtd (in Russian)
4. Lazarev N.V., Levina E.N. Harmful Substances in Industry: A Handbook for Chemists, Engineers, and Physicians. Volume. I. Organic Substances [Vrednye veshchestva v promyshlennosti. Spravochnik dlya khimikov, inzhenerov i vrachei. Tom I. Organicheskie veshchestva]. Leningrad: Khimiya; 1976. (in Russian)
5. Kurdikar D.L., Peppas N.A. Method of determination of initiator efficiency: application to UV polymerizations using 2, 2-dimethoxy-2-phenylacetophenone. Macromolecules. 1994; 27(3): 733–8. https://doi.org/10.1021/ma00081a017
6. Mucci V., Vallo C. Efficiency of 2, 2-dimethoxy-2-phenylacetophenone for the photopolymerization of methacrylate monomers in thick sections. J. Appl. Polym. Sci. 2012; 123(1): 418–25. https://doi.org/10.1002/app.34473
7. Semchikov Yu.D., Kashaev S.Yu., Tikhonova A., Kopylova N.A., Golubev A.A., Eregina N.V. The influence of initiator concentration on the three-dimensional polymerization of acrylic oligomers. Vysokomolekulyarnye soedineniya. Seriya B. 1992; 34(2): 3–6. (in Russian)
8. Vnuk V.V., Ippolitov E.V., Kamaev S.V., Markov M.A., Novikov M.M., Cherebylo S.A. Investigation of the laser photopolymerization process of composite materials based on methacrylic oligomers and silicon powder. Khimicheskaya fizika. 2020; 39(9): 88–93. https://doi.org/10.31857/S0207401X20090137 https://elibrary.ru/qcrlbd (in Russian)
9. Kawasaki Y., Yamaji K., Matsunaga H., Sendo T. Cytotoxicity of the polymerization agent, 2-methyl-4’-(methylthio)-2-morpholinopropiophenone on human monocytes. Biol. Pharm. Bull. 2012; 35(2): 256–9. https://doi.org/10.1248/bpb.35.256
10. Yamaji K., Kawasaki Y., Yoshitome K., Matsunaga H., Sendo T. Quantitation and human monocyte cytotoxicity of the polymerization agent 1-hydroxycyclohexyl phenyl ketone (Irgacure 184) from three brands of aqueous injection solution. Biol. Pharm. Bull. 2012; 35(10): 1821–5. https://doi.org/10.1248/bpb.b12-00210
11. Cook N., Freeman S. Report of 19 cases of photoallergic contact dermatitis to sunscreens seen at the Skin and Cancer Foundation. Australas J. Dermatol. 2001; 42(4): 257–9. https://doi.org/10.1046/j.1440-0960.2001.00531.x
12. Alanko K., Jolanki R., Estlander T., Kanerva L. Occupational allergic contact dermatitis from benzophenone-4 in hair-care products. Contact Dermatitis. 2001; 44(3): 188. https://doi.org/10.1034/j.1600-0536.2001.440308-9.x
13. Nedorost S.T. Facial erythema as a result of benzophenone allergy. J. Am. Acad. Dermatol. 2003; 49(5 Suppl.): S259–61. https://doi.org/10.1016/s0190-9622(03)00440-7
14. ECHA. European chemical agency data base. 2,2-Dimethoxy-1,2-diphenylethan-1-one. Available at: https://echa.europa.eu/da/registration-dossier/-/registered-dossier/5410/.
15. Safety data sheet of the 2,2-Dimethoxy-2-phenylacetophenone according to Regulation (EC) No. 1907/2006. Version 7.3. Sigma Aldrich. Revision Date 12.09.2022. Available at: https://sigmaaldrich.cn/RU/en/sds/aldrich/196118?userType=undefined
16. Information on Hazardous Chemicals and Occupational Diseases. 2,2-Dimethoxy-2-phenylacetophenone. Available at: https://haz-map.com/Agents/19435.
17. Kawasaki Y., Tsuboi C., Yagi K., Morizane M., Masaoka Y., Esumi S., et al. Photoinitiators enhanced 1,2-dichloropropane-induced cytotoxicity in human normal embryonic lung fibroblasts cells in vitro. Environ. Sci. Pollut. Res. Int. 2015; 22(6): 4763–70. https://doi.org/10.1007/s11356-014-3939-8
18. Prozorovskii V.V. The use of the least squares method for probit analysis of lethality curves. Farmakologiya i toksikologiya. 1962; 25(1): 115–9. https://elibrary.ru/zcogzr (in Russian)
Review
For citations:
Fedotova L.A., Mamonov R.A., Pechnikova I.A., Lebed-Sharlevich Ya.I., Manaeva E.S., Potapchenko T.D., Belyaeva N.I., Gollandtseva A.I., Nemtseva Yu.S., Tyurina I.A., Fedortsova D.Yu., Fedortsov I.A., Bolekhan V.N. Assessment of 2,2-dimethoxy-2-phenylacetophenone toxicity and hazard. Hygiene and Sanitation. 2025;104(12):1741-1748. (In Russ.) https://doi.org/10.47470/0016-9900-2025-104-12-1741-1748. EDN: luesxg
JATS XML

































